Ironwood Pharmaceuticals Issues Quarterly Update for Q2 2026

What Happened

• On August 6, 2026, Ironwood Pharmaceuticals, Inc. announced and furnished a press release (Exhibit 99.1) via Form 8-K that provides an update on recent business activities and the company’s results for the quarter ended June 30, 2026. The press release is incorporated by reference into the filing.

Key Details

• Filing date: August 6, 2026 (Form 8-K, Item 2.02).
• Content: press release with business update and results for the quarter ended June 30, 2026 (Exhibit 99.1).
• Exhibit list includes Exhibit 99.1 (press release) and Inline XBRL cover page (Exhibit 104).

Why It Matters

• The furnished press release is the company’s official public update on its quarterly results, business progress and operational condition for the quarter ended June 30, 2026.
• Investors should review Exhibit 99.1 (the press release) and related filings for the detailed earnings, revenue, cash position, and any disclosed operational or pipeline developments that could affect the company’s outlook.